Literature DB >> 22778217

Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Chang Su1, Rebecca L Cunningham, Nataliya Rybalchenko, Meharvan Singh.   

Abstract

Progesterone (P4) is cytoprotective in various experimental models, but our understanding of the mechanisms involved is still incomplete. Our laboratory has implicated brain-derived neurotrophic factor (BDNF) signaling as an important mediator of P4's protective actions. We have shown that P4 increases the expression of BDNF, an effect mediated by the classical P4 receptor (PR), and that the protective effects of P4 were abolished using inhibitors of Trk receptor signaling. In an effort to extend our understanding of the interrelationship between P4 and BDNF signaling, we determined whether P4 influenced BDNF release and examined the role of the classical PR and a putative membrane PR, progesterone receptor membrane component-1 (Pgrmc1), as mediators of this response. Given recent data from our laboratory that supported the role of ERK5 in BDNF release, we also tested whether P4-induced BDNF release was mediated by ERK5. In this study, we found that P4 and the membrane-impermeable P4 (P4-BSA) both induced BDNF release from cultured C6 glial cells and primary astrocytes. Both these cells lack the classical nuclear/intracellular PR but express high levels of membrane-associated PR, including Pgrmc1. Using RNA interference-mediated knockdown of Pgrmc1 expression, we determined that P4-induced BDNF release was dependent on the expression of Pgrmc1, although pharmacological inhibition of the PR failed to alter the effects of P4. Furthermore, the BDNF release elicited by P4 was mediated by ERK5, and not ERK1/2. Collectively, our data describe that P4 elicits an increase in BDNF release from glia via a Pgrmc1-induced ERK5 signaling mechanism and identify Pgrmc1 as a potential therapeutic target for future hormone-based drug development for the treatment of such degenerative diseases as Alzheimer's disease as well as other diseases wherein neurotrophin dysregulation is noted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778217      PMCID: PMC3423611          DOI: 10.1210/en.2011-2177

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  102 in total

1.  Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

Authors:  S Arancibia; M Silhol; F Moulière; J Meffre; I Höllinger; T Maurice; L Tapia-Arancibia
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

2.  Extra-nuclear activation of progesterone receptor in regulating arterial smooth muscle cell migration.

Authors:  Sung-Po Hsu; Thay-Hsiung Chen; Yu-Pei Chou; Li-Ching Chen; Chun-Ting Kuo; Tong-Sheng Lee; Jheng-Jhe Lin; Nen-Chun Chang; Wen-Sen Lee
Journal:  Atherosclerosis       Date:  2011-03-10       Impact factor: 5.162

3.  Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons.

Authors:  Maria Claudia Gonzalez Deniselle; Laura Garay; Susana Gonzalez; Flavia Saravia; Florencia Labombarda; Rachida Guennoun; Michael Schumacher; Alejandro F De Nicola
Journal:  Exp Neurol       Date:  2006-10-17       Impact factor: 5.330

Review 4.  Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.

Authors:  Iqbal Sayeed; Donald G Stein
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

Review 5.  Evidence for a genomic mechanism of action for progesterone receptor membrane component-1.

Authors:  John J Peluso; Josh DeCerbo; Valentina Lodde
Journal:  Steroids       Date:  2012-02-01       Impact factor: 2.668

6.  Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid.

Authors:  J S Rudge; E M Pasnikowski; P Holst; R M Lindsay
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

Review 7.  Estradiol regulation of progesterone synthesis in the brain.

Authors:  Paul Micevych; Kevin Sinchak
Journal:  Mol Cell Endocrinol       Date:  2008-05-03       Impact factor: 4.102

8.  Nonclassical mechanisms of progesterone action in the brain: II. Role of calmodulin-dependent protein kinase II in progesterone-mediated signaling in the hypothalamus of female rats.

Authors:  Bhuvana Balasubramanian; Wendy Portillo; Andrea Reyna; Jian Zhong Chen; Anthony N Moore; Pramod K Dash; Shaila K Mani
Journal:  Endocrinology       Date:  2008-07-10       Impact factor: 4.736

9.  Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling.

Authors:  Jon Nilsen; Roberta Diaz Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

10.  Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.

Authors:  Ikhlas S Ahmed; Hannah J Rohe; Katherine E Twist; Marlene N Mattingly; Rolf J Craven
Journal:  J Pharmacol Exp Ther       Date:  2010-02-17       Impact factor: 4.030

View more
  34 in total

1.  Progesterone antagonism of neurite outgrowth depends on microglial activation via Pgrmc1/S2R.

Authors:  N Bali; J M Arimoto; T E Morgan; C E Finch
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

2.  Cyclic Regulation of Sensory Perception by a Female Hormone Alters Behavior.

Authors:  Sandeepa Dey; Pablo Chamero; James K Pru; Ming-Shan Chien; Ximena Ibarra-Soria; Kathryn R Spencer; Darren W Logan; Hiroaki Matsunami; John J Peluso; Lisa Stowers
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

3.  Let-7i inhibition enhances progesterone-induced functional recovery in a mouse model of ischemia.

Authors:  Trinh Nguyen; Chang Su; Meharvan Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-20       Impact factor: 11.205

Review 4.  Sex differences in brain-derived neurotrophic factor signaling and functions.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 5.  Progesterone, brain-derived neurotrophic factor and neuroprotection.

Authors:  M Singh; C Su
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 6.  The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer's Disease.

Authors:  Milad Hasanpour; Alireza Nourazarian; Mohammad Hossein Geranmayeh; Masoud Nikanfar; Fatemeh Khaki-Khatibi; Reza Rahbarghazi
Journal:  Neuromolecular Med       Date:  2018-05-04       Impact factor: 3.843

7.  Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.

Authors:  E Oral; H Ozcan; T S Kirkan; S Askin; M Gulec; N Aydin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-02       Impact factor: 5.270

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

9.  Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone.

Authors:  S Yousuf; F Atif; I Sayeed; J Wang; D G Stein
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

Review 10.  Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy.

Authors:  Meharvan Singh; Chang Su
Journal:  Brain Res       Date:  2013-01-20       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.